ClinicalTrials.Veeva

Menu

A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts

C

China Medical University

Status

Unknown

Conditions

Human Papilloma Virus

Treatments

Drug: Imiquimod treatment
Device: Local Hyperthermia at 44℃

Study type

Interventional

Funder types

Other

Identifiers

NCT05146895
HH20190606

Details and patient eligibility

About

flat warts are a superficial viral skin disease, extremely common in childhood.Treatment of warts is often difficult and involves different destructive procedures.Although several pharmacological and physical topical treatments are available (keratolytic agents, electrosurgery, cryotherapy, carbon dioxide laser), results are often unsatisfactory in terms of efficacy (frequent recurrence) and cosmetic outcome (scars, inflammatory reactions, transient or permanent hyper- or hypopigmentation).

Mild local Hyperthermia with a certain temperature range has been successfully used in the treatment of some diseases. It has been utilised in the treatment of some neoplasm, fungal and HPV infections. Investigators' study found that local hyperthermia at 44°C could cleared HPV in more than half of the patients with plantar warts. Investigators also note the fact that in patients with multiple lesions, the clearance of the target lesion is commonly followed by clearance of other distant lesions, a phenomenon suggesting that local hyperthermia could aid in establishing a specific immune response to eliminate HPV.So the purpose of the study is to evaluation local hyperthermia in the treatment of flat warts Appropriate control arms were designed for different conditions.

Enrollment

60 estimated patients

Sex

All

Ages

12 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 12-65 years old;
  • diagnosis confirmed;
  • signed informed consent

Exclusion criteria

  • Pregnant woman;
  • Local or systematic treatment within 3 months;
  • Comorbidity of other severe gynecological inflammation,
  • Infection, or tumor;
  • Comorbidity of other serious illnesses;
  • No guarantee of timely treatment and follow-up

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Local Hyperthermia at 44℃ for falt warts
Experimental group
Description:
Local hyperthermia at 44℃ for 30 mins on one lesion region, at days of 1,2,3, 15, 16, 21 and 28.
Treatment:
Device: Local Hyperthermia at 44℃
Imiquimod for Flat Warts
Active Comparator group
Description:
Miquimod treatment: 3 times a week for 1 month
Treatment:
Drug: Imiquimod treatment

Trial contacts and locations

1

Loading...

Central trial contact

Xinghua Gao; Shengnan Zhao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems